Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Rise in research and development in the field of cell-based therapies
3.2.1.3 Technological advancement
3.2.1.4 Expanded applications of transfection technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of transfection technology instruments
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits and reagents
5.3 Equipment
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Physical transfection
6.2.1 Electroporation
6.2.2 Biolistic transfection/ gene guns
6.2.3 Microinjection
6.2.4 Other physical transfection methods
6.3 Biochemical-based transfection
6.3.1 Lipofection
6.3.2 Calcium phosphate transfection
6.3.3 Cationic polymer transfection
6.3.4 DEAE-dextran transfection
6.3.5 Magnet-assisted transfection
6.3.6 Dendrimer-mediated transfection
6.4 Viral-vector based transfection
6.5 Cotransfection
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Therapeutic delivery
7.2.1 Biotherapeutics
7.2.2 Electroimmunotherapy
7.2.3 Electrochemotherapy
7.3 Biomedical research
7.3.1 Gene and protein expression studies
7.3.2 Cancer research
7.3.3 Transgenic models
7.4 Protein production
7.5 Cell-based microarrays
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 CROs and CDMOs
8.4 Academic and research institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Bio-Rad Laboratories, Inc.
10.3 Danaher Corporation
10.4 F. Hoffmann-La Roche Ltd
10.5 Lonza
10.6 MaxCyte, Inc.
10.7 QIAGEN N.V.
10.8 Revvity, Inc.
10.9 Sartorius AG
10.10 Thermo Fisher Scientific, Inc.
